Anti-SO1B1/ SLCO1B1/ HBLRR monoclonal antibody

Anti-SO1B1/ SLCO1B1/ HBLRR antibody for FACS & in-vivo assay

Target products collectionGo to SLCO1B1/SLCO1B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T46814-Ab-1/ GM-Tg-hg-T46814-Ab-2Anti-Human SLCO1B1 monoclonal antibodyHuman
GM-Tg-rg-T46814-Ab-1/ GM-Tg-rg-T46814-Ab-2Anti-Rat SLCO1B1 monoclonal antibodyRat
GM-Tg-mg-T46814-Ab-1/ GM-Tg-mg-T46814-Ab-2Anti-Mouse SLCO1B1 monoclonal antibodyMouse
GM-Tg-cynog-T46814-Ab-1/ GM-Tg-cynog-T46814-Ab-2Anti-Cynomolgus/ Rhesus macaque SLCO1B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T46814-Ab-1/ GM-Tg-felg-T46814-Ab-2Anti-Feline SLCO1B1 monoclonal antibodyFeline
GM-Tg-cang-T46814-Ab-1/ GM-Tg-cang-T46814-Ab-2Anti-Canine SLCO1B1 monoclonal antibodyCanine
GM-Tg-bovg-T46814-Ab-1/ GM-Tg-bovg-T46814-Ab-2Anti-Bovine SLCO1B1 monoclonal antibodyBovine
GM-Tg-equg-T46814-Ab-1/ GM-Tg-equg-T46814-Ab-2Anti-Equine SLCO1B1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T46814-Ab-1/ GM-Tg-hg-T46814-Ab-2; GM-Tg-rg-T46814-Ab-1/ GM-Tg-rg-T46814-Ab-2;
GM-Tg-mg-T46814-Ab-1/ GM-Tg-mg-T46814-Ab-2; GM-Tg-cynog-T46814-Ab-1/ GM-Tg-cynog-T46814-Ab-2;
GM-Tg-felg-T46814-Ab-1/ GM-Tg-felg-T46814-Ab-2; GM-Tg-cang-T46814-Ab-1/ GM-Tg-cang-T46814-Ab-2;
GM-Tg-bovg-T46814-Ab-1/ GM-Tg-bovg-T46814-Ab-2; GM-Tg-equg-T46814-Ab-1/ GM-Tg-equg-T46814-Ab-2
Products NameAnti-SLCO1B1 monoclonal antibody
Formatmab
Target NameSLCO1B1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLCO1B1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SO1B1/ SLCO1B1/ HBLRR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000189human SLCO1B1 Lentivirus plasmid
    ORF Viral VectorvGMLV000189human SLCO1B1 Lentivirus particle


    Target information

    Target IDGM-T46814
    Target NameSLCO1B1
    Gene ID10599,705308
    Gene Symbol and SynonymsHBLRR,LST-1,LST1,OATP-C,OATP1B1,OATP2,OATPC,SLC21A6,SLCO1B1
    Uniprot AccessionQ9Y6L6
    Uniprot Entry NameSO1B1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000134538
    Target ClassificationTumor-associated antigen (TAA)

    The target: SLCO1B1, gene name: SLCO1B1, also named as HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6. This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.